We are live on ! Find out more
HURA

TuHURA Biosciences

9 hedge funds and large institutions have $682K invested in TuHURA Biosciences in 2018 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

603% more capital invested

Capital invested by funds: $97K → $682K (+$585K)

80% more funds holding

Funds holding: 59 (+4)

0% more ownership

Funds ownership: 0%0% (+0%)

Holders
9
Holders Change
+4
Holders Change %
+80%
% of All Funds
0.2%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
2
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

HURA Hedge Fund Activity: Q4 2018 in Review

9 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q4 2018, worth a combined $682K — up 603% from $97K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new HURA positions and 0 closed out — a net gain of 4 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $786K. The largest seller was TrustCore Financial Services, cutting an estimated $4K.

  • 9 institutional investors held TuHURA Biosciences (HURA) as of Q4 2018, up from 5 in Q3 2018.
  • Funds reported $682K of TuHURA Biosciences stock for Q4 2018, up 603% quarter-over-quarter.
  • 4 funds opened new TuHURA Biosciences positions in Q4 2018 and 0 closed out, a net change of +4 holders.
  • The largest TuHURA Biosciences buyer in Q4 2018 was Sabby Management, an estimated $786K added.
  • The largest TuHURA Biosciences seller in Q4 2018 was TrustCore Financial Services, an estimated $4K sold.

Based on aggregated 13F filings for Q4 2018.